FEBUXOSTAT
| Brand name | ULORIC |
|---|---|
| Active ingredient | FEBUXOSTAT |
| Strength | 40MG |
| Dosage form | TABLET |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | February 2009 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 9107912 | September 2031 | use U-1346 |
| 8372872 | September 2031 | use U-1346 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.